Open AccessCombinatorial assessment of ctDNA release and mutational burden predicts anti‐PD(L)1 therapy outcome in nonsmall‐cell lung cancer
Author(s) -
Fang Wenfeng,
Ma Yuxiang,
Yin Jiani C.,
Zhou Huaqiang,
Wang Fufeng,
Bao Hua,
Wang Ao,
Wu Xue,
Hong Shaodong,
Yang Yunpeng,
Huang Yan,
Zhao Hongyun,
Shao Yang W.,
Zhang Li
Publication year - 2020
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.8
Subject(s) - medicine , liquid biopsy , immunotherapy , biomarker , oncology , lung cancer , cancer , disease , immune checkpoint , circulating tumor cell , targeted therapy , bioinformatics , metastasis , biology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom